Adrien Bouglé on Comparison Between Regional Citrate Anticoagulation and Systemic Heparin
Adrien Bouglé, Head of Cardiac ICU and Anesthesiology, Full Professor, Sorbonne University, La Pitié – Salpêtrière, shared on LinkedIn:
”Very pleased to share our latest multicentric study comparing regional citrate anticoagulation and systemic heparin in patients undergoing VA-ECMO and continuous renal replacement therapy.
RCA was associated with a significantly lower risk of CRRT filter thrombosis, without increasing bleeding or severe metabolic complications — supporting its use in this high-risk population.”
Read the full article here.
Article: Comparison between regional citrate anticoagulation and systemic heparin anticoagulation in patients undergoing continuous renal replacement therapy and venoarterial extracorporeal membrane oxygenation: A retrospective multicentric study
Authors: Axel Hirwe, Edris Omar, Pierre-Grégoire Guinot, Antoine Beurton, Nicolas Nesseler, Alexandre Mansour, Vivien Berthoud, Alexandre Ouattara, Stéphanie Rouanet, Guillaume Lebreton, Geoffroy Hariri, Adrien Bouglé
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda